The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Pharmaceutical Asset Managements-Global Market Insights and Sales Trends 2024
Synopsis
The global Pharmaceutical Asset Managements market size is expected to reach US$ 155.7 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Asset Managements in various end use industries. The expanding demands from the Anti-Drug Counterfeiting, Supply Chain Management and Other, are propelling Pharmaceutical Asset Managements market. Hardware (Pharma Asset), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Software (Pharma Asset) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Asset Managements, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Asset Managements market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Asset Managements market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Asset Managements sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Asset Managements covered in this report include McKesson Corporation, Cerner Corporation, Siemens Healthcare, GE Healthcare, Allscripts, Epic System and IBM Corporation, etc.
The global Pharmaceutical Asset Managements market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation
Global Pharmaceutical Asset Managements market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Asset Managements market, Segment by Type:
Hardware (Pharma Asset)
Software (Pharma Asset)
Global Pharmaceutical Asset Managements market, by Application
Anti-Drug Counterfeiting
Supply Chain Management
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Asset Managements companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Pharmaceutical Asset Managements market size is expected to reach US$ 155.7 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Pharmaceutical Asset Managements in various end use industries. The expanding demands from the Anti-Drug Counterfeiting, Supply Chain Management and Other, are propelling Pharmaceutical Asset Managements market. Hardware (Pharma Asset), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Software (Pharma Asset) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pharmaceutical Asset Managements, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Pharmaceutical Asset Managements market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Pharmaceutical Asset Managements market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pharmaceutical Asset Managements sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Pharmaceutical Asset Managements covered in this report include McKesson Corporation, Cerner Corporation, Siemens Healthcare, GE Healthcare, Allscripts, Epic System and IBM Corporation, etc.
The global Pharmaceutical Asset Managements market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
McKesson Corporation
Cerner Corporation
Siemens Healthcare
GE Healthcare
Allscripts
Epic System
IBM Corporation
Global Pharmaceutical Asset Managements market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Pharmaceutical Asset Managements market, Segment by Type:
Hardware (Pharma Asset)
Software (Pharma Asset)
Global Pharmaceutical Asset Managements market, by Application
Anti-Drug Counterfeiting
Supply Chain Management
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pharmaceutical Asset Managements companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Pharmaceutical Asset Managements
1.1 Pharmaceutical Asset Managements Market Overview
1.1.1 Pharmaceutical Asset Managements Product Scope
1.1.2 Pharmaceutical Asset Managements Market Status and Outlook
1.2 Global Pharmaceutical Asset Managements Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pharmaceutical Asset Managements Market Size by Region (2018-2029)
1.4 Global Pharmaceutical Asset Managements Historic Market Size by Region (2018-2023)
1.5 Global Pharmaceutical Asset Managements Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pharmaceutical Asset Managements Market Size (2018-2029)
1.6.1 North America Pharmaceutical Asset Managements Market Size (2018-2029)
1.6.2 Europe Pharmaceutical Asset Managements Market Size (2018-2029)
1.6.3 Asia-Pacific Pharmaceutical Asset Managements Market Size (2018-2029)
1.6.4 Latin America Pharmaceutical Asset Managements Market Size (2018-2029)
1.6.5 Middle East & Africa Pharmaceutical Asset Managements Market Size (2018-2029)
2 Pharmaceutical Asset Managements Market by Type
2.1 Introduction
2.1.1 Hardware (Pharma Asset)
2.1.2 Software (Pharma Asset)
2.2 Global Pharmaceutical Asset Managements Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pharmaceutical Asset Managements Historic Market Size by Type (2018-2023)
2.2.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pharmaceutical Asset Managements Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pharmaceutical Asset Managements Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pharmaceutical Asset Managements Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pharmaceutical Asset Managements Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pharmaceutical Asset Managements Revenue Breakdown by Type (2018-2029)
3 Pharmaceutical Asset Managements Market Overview by Application
3.1 Introduction
3.1.1 Anti-Drug Counterfeiting
3.1.2 Supply Chain Management
3.1.3 Other
3.2 Global Pharmaceutical Asset Managements Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pharmaceutical Asset Managements Historic Market Size by Application (2018-2023)
3.2.2 Global Pharmaceutical Asset Managements Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pharmaceutical Asset Managements Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pharmaceutical Asset Managements Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pharmaceutical Asset Managements Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pharmaceutical Asset Managements Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pharmaceutical Asset Managements Revenue Breakdown by Application (2018-2029)
4 Pharmaceutical Asset Managements Competition Analysis by Players
4.1 Global Pharmaceutical Asset Managements Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmaceutical Asset Managements as of 2022)
4.3 Date of Key Players Enter into Pharmaceutical Asset Managements Market
4.4 Global Top Players Pharmaceutical Asset Managements Headquarters and Area Served
4.5 Key Players Pharmaceutical Asset Managements Product Solution and Service
4.6 Competitive Status
4.6.1 Pharmaceutical Asset Managements Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 McKesson Corporation
5.1.1 McKesson Corporation Profile
5.1.2 McKesson Corporation Main Business
5.1.3 McKesson Corporation Pharmaceutical Asset Managements Products, Services and Solutions
5.1.4 McKesson Corporation Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.1.5 McKesson Corporation Recent Developments
5.2 Cerner Corporation
5.2.1 Cerner Corporation Profile
5.2.2 Cerner Corporation Main Business
5.2.3 Cerner Corporation Pharmaceutical Asset Managements Products, Services and Solutions
5.2.4 Cerner Corporation Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.2.5 Cerner Corporation Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Pharmaceutical Asset Managements Products, Services and Solutions
5.3.4 Siemens Healthcare Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.3.5 GE Healthcare Recent Developments
5.4 GE Healthcare
5.4.1 GE Healthcare Profile
5.4.2 GE Healthcare Main Business
5.4.3 GE Healthcare Pharmaceutical Asset Managements Products, Services and Solutions
5.4.4 GE Healthcare Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.4.5 GE Healthcare Recent Developments
5.5 Allscripts
5.5.1 Allscripts Profile
5.5.2 Allscripts Main Business
5.5.3 Allscripts Pharmaceutical Asset Managements Products, Services and Solutions
5.5.4 Allscripts Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.5.5 Allscripts Recent Developments
5.6 Epic System
5.6.1 Epic System Profile
5.6.2 Epic System Main Business
5.6.3 Epic System Pharmaceutical Asset Managements Products, Services and Solutions
5.6.4 Epic System Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.6.5 Epic System Recent Developments
5.7 IBM Corporation
5.7.1 IBM Corporation Profile
5.7.2 IBM Corporation Main Business
5.7.3 IBM Corporation Pharmaceutical Asset Managements Products, Services and Solutions
5.7.4 IBM Corporation Pharmaceutical Asset Managements Revenue (US$ Million) & (2018-2023)
5.7.5 IBM Corporation Recent Developments
6 North America
6.1 North America Pharmaceutical Asset Managements Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pharmaceutical Asset Managements Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Asset Managements Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pharmaceutical Asset Managements Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Asset Managements Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pharmaceutical Asset Managements Market Dynamics
11.1 Pharmaceutical Asset Managements Industry Trends
11.2 Pharmaceutical Asset Managements Market Drivers
11.3 Pharmaceutical Asset Managements Market Challenges
11.4 Pharmaceutical Asset Managements Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
